>> Global Ischemia Foundation(GIF) > Medical Advisory Board      







Dr. S. Thomas Carmichael, Dr. W. Dalton Dietrich, Dr. Jeffrey Englander, Dr. Curt Freed,

Dr. Myron D. Ginsberg, Dr. William Mobley, Dr. Jack Parent, Dr. Dennis Steindler, Michelle Tipton-Burton

Medical Advisory Board Bios :

S. Thomas Carmichael

is a neurologist and neuroscientist in the Department of Neurology at the Geffen School of Medicine at UCLA. Dr. Carmichael is an Assistant Professor with active laboratory and clinical interests in stroke and neurorehabilitation, and how the brain repairs from injury. He received his M.D. and Ph.D. degrees from Washington University School of Medicine in 1993 and 1994, and completed a Neurology residency at Washington University School of Medicine. Dr. Carmichael was a Howard Hughes Medical Institute postdoctoral fellow at UCLA from 1998-2001, studying mechanisms of axonal sprouting, with a clinical emphasis on neurorehabilitation and stroke. He has been on the UCLA faculty since 2001. Dr. Carmichael’s laboratory studies the molecular and cellular mechanisms of neural repair after stroke and other forms of brain injury. This research focuses on the processes of axonal sprouting and neural stem cell responses after stroke, and on neural stem cell transplantation. Dr. Carmichael is an attending physician on the Neurorehabilitation and Stroke clinical services at UCLA.

See: http://www.carmichaellab.neurology.ucla.edu

William Dalton Dietrich, III, PhD

Kinetic Concepts Distinguished Chair in Neurosurgery Professor of Neurological Surgery, Neurology, and Cell Biology and Anatomy Scientific Director, The Miami Project to Cure Paralysis Vice Chairman for Academic Affairs, Department of Neurological Surgery

Dr. Dietrich received his Ph.D. in Anatomy (in the laboratory of Dr. J.T. Povlishock) from the Medical College of Virginia in 1979. Following completion of his Ph.D. requirements, Dr. Dietrich completed a postdoctoral fellowship in the Department of Pharmacology (Dr. O.H. Lowry) at Washington University, St. Louis, MO, 1981. In 1981, Dr. Dietrich joined the Department of Neurology at the University of Miami School of Medicine as an Assistant Professor, with a joint appointment in Cell Biology and Anatomy; in 1986, he was promoted to Associate Professor with Tenure, and in 1993 attained the rank of Professor. Dr. Dietrich served as Vice-Chairman for Basic Science in the Department of Neurology from 1995 to 1997, when he accepted the positon of Scientific Director of The Miami Project to Cure Paralysis. Dr. Dietrich has published 50 book chapters, 220 refereed journal articles, 256 abstracts, and 20 editorial comments. He has been a thesis/dissertation advisor to 20 predoctoral students and has trained 31 postdoctoral fellows in his laboratory.

Jeffrey Englander, MD
Santa Clara Valley Medical Center

Dr. Englander completed his medical education at the Case Western Reserve University School of Medicine in Cleveland, Ohio and his residency at Tufts New England and Boston V.A. Medical Centers. In addition, he completed a Fellowship in Behavioral Neurology and Aphasia at Boston University Department of Neurology. Dr. Englander is Board Certified in Physical Medicine and Rehabilitation as well as Internal Medicine. His primary research interests are investigating means to improve the recovery of individuals with brain injuries. He has been the Project Director for the Model System Grant for Traumatic Brain Injury at Santa Clara Valley Medical Center, continuously funded by the U.S. Department of Education since 1987.

Curt R. Freed, MD,

Professor and division head of clinical pharmacology and toxicology at the CU School of Medicine University of Colorado in Denver and director of the National Parkinson Foundation Center of Excellence.

Dr. Freed is considered one of the top fetal cell transplant researchers in the U.S. and is the author of Healing the Brain which recounts test on the implantation and the "surgical method (involved), in which microscopic "noodles" of fetal brain tissue were implanted in the brains of suffering patients."

Myron D. Ginsberg, M.D.

Peritz Scheinberg Professor of Neurology Director, Cerebral Vascular Disease Research Center
Co-Director, Neurotrauma Research Center Professor of Psychology

Dr. Ginsberg directs the Cerebral Vascular Disease Research Center, a multidisclipinary research
group devoted to experimental studies of the mechanisms by which the brain is injured by cerebral ischemia (deprivation of blood flow, stroke), hypoxia (deprivation of oxygen), and traumatic head injury. We are also investigating how pharmaceutical agents and other strategies may be used to protect the injured brain. Our studies apply many complementary research strategies to standardized experimental models of focal ischemia (stroke), global ischemia (resembling cardiac arrest), and fluid-percussion head injury. Areas of particular current interest include: 1) the protective effects of mild brain temperature reductions (hypothermia) and the injurious effects of fever (hyperthermia); 2) the ability of novel
drugs and agents to protect the brain from damage produced by stroke or trauma; 3) expression of novel genetic programs by the injured brain which may either contribute to injury or protect from it; and 4) the manner in which the injured brain is capable of recovering function (neural plasticity and reorganization). 

William C. Mobley, M.D., Ph.D.

Professor and Chair of the Department of Neurology and Neurological Sciences at Stanford University . After completing undergraduate training in chemistry and zoology at the University of Nebraska at Lincoln.

Mobley received the medical degree and doctorate in neuroscience from Stanford University . He trained in pathology and pediatrics at the Stanford University Hospital and completed a residency and fellowship in neurology at Johns Hopkins University Hospital , where he also was chief resident in pediatric neurology. In 1985, he joined the faculty of the University of California , San Francisco School of Medicine where he rose to the rank of professor of neurology, pediatrics and the neuroscience program and served as the director of child neurology. In 1991, he was named Derek Denny Brown Scholar of the American Neurological Association. Since 1997 he has been the Chair of the Department of Neurology and Neurological Sciences at Stanford University and holds the John E. Cahill Family Endowed Chair. He also serves as co-Director of the Stanford Brain Research Institute. His laboratory studies the signaling biology of neurotrophic factors in the normal brain and in animal models of neurodegenerative disorders, such as Alzheimer's disease and Down syndrome. He is the recipient of both the Zenith Award and the Temple Award from the Alzheimer's Association and is a Fellow of the Royal College of Physicians. Mobley serves as Editor of the Neurobiology of Disease, as a member of the American Society for Experimental Neurotherapeutics, was former president of the Association of University Professors of Neurology and president-elect of The Professors of Child Neurology.

Jack M. Parent, MD
Assistant Professor of Neurology, Director of the Neurodevelopment and Regeneration Laboratory and Acting Director of the Epilepsy Research Program at the University of Michigan Medical Center, Ann Arbor, Michigan.

Dr. Parent received an A.B. with distinction in Human Biology at Stanford University and his M.D. at Yale University School of Medicine. He completed medical internship, neurology residency, clinical fellowship training in epilepsy and clinical neurophysiology, and a post-doctoral neuroscience research fellowship at the University of California, San Francisco. Dr. Parent established his laboratory at the University of Michigan in 2000, where he studies the neural stem cell biology and the effects of brain injury on adult neurogenesis using animal models of epilepsy and stroke. Dr. Parent is a member of the Epilepsy Foundation of America Research Council, is an Associate Editor of Neuroscience Letters, and is on the editorial boards of Experimental Neurology and Epilepsy Currents. He has received several awards for his research, including a Junior Investigator Award from the American Epilepsy Society, a Paul Beeson Physician Faculty Scholars in Aging Award, and the Dreifuss-Penry Epilepsy Award from the American Academy of Neurology. Dr. Parent’s current research interests include mechanisms of postnatal brain development and neural stem cell regulation, the influence of brain injury on endogenous neural stem cells, and the use of neural stem cells for reparative therapy of brain disorders. Dr. Parent has joined the advisory board of GIF with the goal of increasing the pace with which basic research advances are applied to treat clinical brain disorders.

Dennis A. Steindler, PhD
Executive Director And Joseph J. Bagnor/Shands Professor of Medical Research
McKnight Brain Institute, The University of Florida, Gainesville, Florida

Dr. Steindler received his doctorate in Anatomy and neuroscience from the University of California, San Francisco. After postdoctoral studies at the Max-Planck-Institute for Biophysical Chemistry in Germany, Dr. Steindler began his studies of brain development and injury as a faculty member at Michigan State University and the University of Tennessee Memphis. He is currently the Executive Director of the McKnight Brain Institute of the University of Florida, and the Joseph J. Bagnor/Shands Professor of Medical Research, and a member of the Program in Adult Stem Cell Biology and Regenerative Medicine of the University of Florida College of Medicine. Besides directing a large developmental neurobiology group, Dr. Steindler has been studying the growth and transplantation of brain and stem cells for over 25 years. He is also responsible for reviewing manuscripts and grants for a variety of journals and funding agencies. He currently is an advisor to the California Institute for Regenerative Medicine, a member of the Scientific Advisory Board of the Michael J. Fox Foundation for Parkinson’s Research, and retains positions on the editorial boards of the journals The Journal of Neuroscience, GLIA, Experimental Neurology, The Journal of Neurocytology, Gene Expression, and Developmental Brain Research. His recent publications in the international journals of medicine and science, The Lancet, and Proceedings of the National Academy of Sciences, set forth plans for the use of stem cells and regenerative medicine for developing therapeutics for a variety of neurological diseases, including Parkinson’s Disease, cancer, and stroke.

Dr Steindler's motivation for being a part of the GIF is to see discoveries in neuroscience and stem cell biology reach the clinics for a variety of neurological diseases, including hypoxic ischemic encephalopathy. Dr Steindler can be contacted via email.

Michelle Tipton-Burton MS, OTR/L
Therapy Director, Day Treatment Program, Santa Clara Valley Medical Center

Michelle received her BS and MS degrees in Occupational therapy from San Jose State University. She has specialized in treating brain injury and other neurological disorders for the last 16 years. Michelle is currently working in the Day Treatment Program at Santa Clara Valley Medical Center and in private practice. She has also been a clinical instructor at San Jose State University and continues to lecture there. As a private clinician she works with clients in their home, community and work environments and serves as an expert witness. Over the last 15 years, Michelle has researched and lectured on various topics on brain injury including behavioral management, upper extremity casting, and seating and positioning. Currently Michelle is involved in a research study evaluating the use of cognitive orthotic devices in the brain injury population and continues to actively treat clients with brain injuries and anoxia in home and hospital settings.





Copyright © 2005-2006 Global Ischemia Foundation . All Rights Reserved.